AI Engines For more Details: Perplexity Kagi Labs You
Digestive Health: Fiber is known for its beneficial effects on digestive health. It adds bulk to stool, softens it, and helps it pass more easily through the digestive tract, reducing the risk of constipation and promoting regular bowel movements. Adequate fiber intake can also help to prevent or alleviate symptoms of digestive disorders such as diverticulosis, hemorrhoids, and irritable bowel syndrome (IBS).
Weight Management: High-fiber foods tend to be more filling and satisfying, which can help to control appetite and reduce calorie intake. Fiber-rich foods take longer to digest, helping to keep you feeling full for longer periods and reducing the likelihood of overeating. Including plenty of fiber in your diet can be beneficial for weight management and may help to prevent obesity and related metabolic disorders.
Blood Sugar Control: Fiber slows down the absorption of sugar in the bloodstream, which can help to regulate blood sugar levels and prevent spikes in insulin production. This is particularly beneficial for individuals with diabetes or insulin resistance. Including fiber-rich foods in meals can help to stabilize blood sugar levels and improve glycemic control.
Heart Health: Fiber has been shown to have beneficial effects on heart health by helping to lower cholesterol levels and reduce the risk of heart disease. Soluble fiber, in particular, binds to cholesterol in the digestive tract and prevents it from being absorbed into the bloodstream, leading to lower LDL (bad) cholesterol levels. High-fiber diets are associated with a reduced risk of coronary artery disease, stroke, and other cardiovascular conditions.
Gut Microbiota: Fiber serves as a prebiotic, providing fuel for beneficial bacteria in the gut microbiota. These bacteria ferment fiber in the colon, producing short-chain fatty acids (SCFAs) that help to nourish the cells lining the colon and support overall gut health. A healthy balance of gut bacteria is essential for immune function, inflammation regulation, and protection against gastrointestinal disorders.
Cancer Prevention: Some research suggests that a high-fiber diet may help to reduce the risk of certain types of cancer, particularly colorectal cancer. Fiber promotes regular bowel movements, which may help to prevent the accumulation of carcinogens in the colon. Additionally, SCFAs produced by gut bacteria from fiber fermentation have been shown to have anti-cancer effects.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Clostridium beijerinckii | Reduces |
| species | Clostridium butyricum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Allergic Rhinitis (Hay Fever) | 0.5 | 0.2 | 1.5 |
| Allergies | 0.3 | 0.5 | -0.67 |
| Allergy to milk products | 0.5 | 0.9 | -0.8 |
| Alzheimer's disease | 0.8 | -0.8 | |
| Ankylosing spondylitis | 0.2 | -0.2 | |
| Anorexia Nervosa | 0.5 | -0.5 | |
| Antiphospholipid syndrome (APS) | 0.6 | -0.6 | |
| Asthma | 0.8 | 0.2 | 3 |
| Atherosclerosis | 0.5 | -0.5 | |
| Atrial fibrillation | 0.6 | -0.6 | |
| Autism | 1.4 | 1.3 | 0.08 |
| Bipolar Disorder | 0.6 | -0.6 | |
| Carcinoma | 0.6 | -0.6 | |
| Cerebral Palsy | 0.5 | 0.5 | |
| Chronic Fatigue Syndrome | 0.8 | 0.8 | 0 |
| Chronic Urticaria (Hives) | 0.5 | 0.5 | |
| Coagulation / Micro clot triggering bacteria | 0.2 | -0.2 | |
| Colorectal Cancer | 0.6 | -0.6 | |
| COVID-19 | 0.7 | 1 | -0.43 |
| Crohn's Disease | 1.1 | 1.2 | -0.09 |
| cystic fibrosis | 0.6 | -0.6 | |
| deep vein thrombosis | 0.2 | -0.2 | |
| Depression | 0.5 | 1.3 | -1.6 |
| Eczema | 0.3 | 0.8 | -1.67 |
| Fibromyalgia | 0.5 | 0.5 | 0 |
| Functional constipation / chronic idiopathic constipation | 0.5 | 1.1 | -1.2 |
| gallstone disease (gsd) | 0.5 | 0.5 | |
| Generalized anxiety disorder | 0.7 | -0.7 | |
| giant cell arteritis | 0.3 | 0.5 | -0.67 |
| Hashimoto's thyroiditis | 0.6 | 0.2 | 2 |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.4 | -0.4 | |
| hypercholesterolemia (High Cholesterol) | 0.5 | 0.5 | |
| hypersomnia | 0.6 | -0.6 | |
| hypertension (High Blood Pressure | 0.6 | 0.6 | 0 |
| IgA nephropathy (IgAN) | 0.5 | -0.5 | |
| Inflammatory Bowel Disease | 1.3 | -1.3 | |
| Intelligence | 0.5 | 0.3 | 0.67 |
| Irritable Bowel Syndrome | 1.7 | 0.6 | 1.83 |
| Liver Cirrhosis | 0.5 | 1.1 | -1.2 |
| Long COVID | 0.8 | 0.8 | |
| ME/CFS with IBS | 0.5 | 0.5 | |
| ME/CFS without IBS | 0.8 | 0.8 | |
| Menopause | 0.2 | -0.2 | |
| Metabolic Syndrome | 0.5 | 1.7 | -2.4 |
| Mood Disorders | 0.7 | 1.3 | -0.86 |
| Multiple Sclerosis | 0.7 | -0.7 | |
| myasthenia gravis | 0.3 | -0.3 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 0.5 | |
| Obesity | 0.7 | 1.7 | -1.43 |
| obsessive-compulsive disorder | 0.8 | -0.8 | |
| Osteoarthritis | 0.5 | 0.5 | |
| Osteoporosis | 0.5 | 0.5 | |
| Parkinson's Disease | 0.2 | 1 | -4 |
| Polycystic ovary syndrome | 0.8 | 0.5 | 0.6 |
| Postural orthostatic tachycardia syndrome | 0.5 | 0.5 | |
| Psoriasis | 0.5 | 0.5 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 1.4 | -3.67 |
| Rosacea | 0.5 | -0.5 | |
| Schizophrenia | 0.7 | 1.1 | -0.57 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.8 | -0.8 | |
| Stress / posttraumatic stress disorder | 0.5 | 0.5 | |
| Systemic Lupus Erythematosus | 0.3 | 0.6 | -1 |
| Type 1 Diabetes | 0.5 | -0.5 | |
| Type 2 Diabetes | 1.7 | -1.7 | |
| Ulcerative colitis | 0.5 | 1.3 | -1.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.